Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study
| Autor: | Van Cutsem, E. *, Yoshino, T., Lenz, H.J., Lonardi, S., Falcone, A., Limón, M.L., Saunders, M., Sobrero, A., Park, Y.S., Ferreiro, R., Hong, Y.S., Tomasek, J., Taniguchi, H., Ciardiello, F., Stoehr, J., Oum’Hamed, Z., Vlassak, S., Studeny, M., Argiles, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2018 29(9):1955-1963 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|